In late June, the FDA approved PHESGO™ (pertuzumab/ trastuzumab/ hyaluronidase-zzxf), a treatment that can be injected under the skin, to treat metastatic and early-stage HER2 positive breast cancer. Because it is given as an injection, PHESGO™ can be given by a healthcare professional in your home, and takes less time than an infusion.
Last Modified on March 4, 2021
